Astec LifeSciences Limited (BOM:533138)

Market Cap	13.41B -27.3%
Revenue (ttm)	4.41B +9.3%
Net Income	-665.97M
EPS	-30.16
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,373
Open	602.10
Previous Close	601.20
Day's Range	601.40 - 618.90
52-Week Range	512.35 - 936.00
Beta	n/a
Analysts	Hold
Price Target	670.00 (+11.17%)
Earnings Date	Jul 31, 2026

About Astec LifeSciences

Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservatives. It also provides herbicides, inse...

• Industry: Agricultural Chemicals
• Founded: 1994
• Employees: 471
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 533138

Financial Performance

In fiscal year 2026, Astec LifeSciences's revenue was 4.48 billion, an increase of 17.53% compared to the previous year's 3.81 billion. Losses were -809.18 million, -39.95% less than in 2025.

Analyst Summary

According to 2 analysts, the average rating for 533138 stock is "Hold." The 12-month stock price target is ₹670.00, which is an increase of 11.17% from the latest price.

Price Target

₹670.00

(11.17% upside)

Analyst Consensus: Hold

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error